In DLBCL, expression of miR-665 can suppress tumor progression by targeting and inhibiting LIM and SH3 domain protein 1 (LASP1) and MYC, both essential for invasion, migration, and cell proliferation (Wang et al., 2022; Miao et al., 2019). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.